Galapagos N.V.
General ticker "GLPGF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $2.0B (TTM average)
Galapagos N.V. follows the US Stock Market performance with the rate: 16.2%.
Estimated limits based on current volatility of 0.0%: low 28.08$, high 28.08$
Factors to consider:
- Total employees count: 435 as of 2015
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [25.36$, 40.35$]
- 2026-12-31 to 2027-12-31 estimated range: [25.05$, 40.15$]
Short-term GLPGF quotes
Long-term GLPGF plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | €239.72MM | €275.65MM | €1,111.83MM |
| Operating Expenses | €327.99MM | €463.99MM | €642.35MM |
| Operating Income | €-88.26MM | €-188.34MM | €469.48MM |
| Non-Operating Income | €93.89MM | €185.25MM | €-168.72MM |
| Interest Expense | €1.65MM | €0.32MM | €2.86MM |
| R&D Expense | €241.29MM | €335.46MM | €459.25MM |
| Income(Loss) | €5.62MM | €-3.08MM | €300.76MM |
| Taxes | €9.61MM | €-1.80MM | €-18.61MM |
| Profit(Loss)* | €211.70MM | €74.08MM | €320.76MM |
| Stockholders Equity | €2,795.57MM | €2,896.94MM | €3,234.66MM |
| Inventory | €73.98MM | €51.19MM | €22.48MM |
| Assets | €4,357.40MM | €4,135.72MM | €3,405.24MM |
| Operating Cash Flow | €-405.97MM | €-320.03MM | €-196.93MM |
| Capital expenditure | €19.27MM | €82.11MM | €13.70MM |
| Investing Cash Flow | €71.19MM | €220.60MM | €228.28MM |
| Financing Cash Flow | €-5.00MM | €-4.92MM | €-3.27MM |
| Earnings Per Share** | €3.21 | €1.12 | €4.87 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.